Toll-Like Receptor 4-Mediated Myeloid Differentiation Factor 88-Dependent Signaling Pathway Is Activated by Cerebral Ischemia-Reperfusion in Hippocampal CA1 Region in Mice

被引:29
|
作者
Gao, Yin [1 ,2 ]
Fang, Xiubin [1 ]
Sun, He [2 ]
Wang, Yu [2 ]
Yao, Li Jie [2 ]
Li, Jing Ping [2 ]
Tong, Yue [1 ]
Zhang, Baohui [1 ]
Liu, Yuli [1 ]
机构
[1] China Med Univ, Dept Neurobiol, Shenyang 110001, Peoples R China
[2] Qiqihar Med Univ, Basic Med Sch, Qiqihar 161042, Peoples R China
关键词
Toll-like receptor 4; ischemia; reperfusion; antibodies-blocking; NF-KAPPA-B; INNATE IMMUNITY; MYD88-INDEPENDENT PATHWAY; RAT; INJURY; ISCHEMIA/REPERFUSION; DAMAGE; BRAIN; TLR4;
D O I
10.1248/bpb.32.1665
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The Toll-like receptor 4 (TLR4)-mediated myeloid differentiation factor 88 (MyD88)-dependent signaling pathway plays an essential role in inflammation resulting from invading microbes. However, whether the signaling pathway is activated in the inflammatory reaction of cerebral ischemia-reperfusion and its mechanism is still unclear. In this experiment mice were randomly divided into sham group, ischemia/reperfusion group and TLR4-blocked group with different time points of reperfusion at 12, 24, 48 and 72 h. Mice cerebral ischemia was induced by occlusion of common carotid arteries (CCA) bilaterally. TLR4 signaling pathway was inhibited using specific anti-TLR4 binding protein to prevent TLR4 from interacting with its receptors. We determined the result of TLR4 antibodies-blocking and mice cerebral ischemia-reperfusion injuries by Western blot, and evaluated neuronal damage in the hippocampus. We also determined expression of TLR4 mRNA and MyD88 mRNA by in situ hybridization (ISH), activation of nuclear factor (NF)-kappa B by electrophoretic mobility-shift analysis (EMSA), and expression of interrleukin (IL)-1 beta protein by Western blot. The results demonstrated that TLR4-mediated MyD88-dependent signaling pathway activated by ischemia-reperfusion may be involved in the mechanism of ischemia-reperfusion through upregulation of NF-kappa B, IL-1 beta.
引用
收藏
页码:1665 / 1671
页数:7
相关论文
共 50 条
  • [31] TcpC inhibits toll-like receptor signaling pathway by serving as an E3 ubiquitin ligase that promotes degradation of myeloid differentiation factor 88
    Fang, Jia-qi
    Ou, Qian
    Pan, Jun
    Fang, Jie
    Zhang, Da-yong
    Qiu, Miao-qi
    Li, Yue-qi
    Wang, Xiao-Hui
    Yang, Xue-yu
    Chi, Zhe
    Gao, Wei
    Guo, Jun-ping
    Miethke, Thomas
    Pan, Jian-ping
    PLOS PATHOGENS, 2021, 17 (03)
  • [32] Transforming growth factor-β-activated kinase 1 resistance limits glucocorticoid responsiveness to Toll-like receptor 4-mediated inflammation
    Kong, Fansheng
    Laryea, Gloria
    Liu, Zhiwei
    Bhattacharyya, Sandip
    IMMUNOLOGY, 2015, 145 (01) : 136 - 149
  • [33] miR-139-5p protects septic mice with acute lung injury by inhibiting Toll-like receptor 4/Myeloid differentiation factor 88/Nuclear factor-κB signaling pathway
    Zhang, Xiuxiu
    Liu, Xin
    Chang, Rui
    Li, Yue
    CLINICS, 2021, 76
  • [34] Chelidonine Attenuates Sepsis-Induced Acute Lung Injury via Suppressing Toll-like Receptor 4/Myeloid Differentiation Factor 88/Nuclear Factor-κB Signaling Pathway in Newborn Mice
    Adili, Ayinuerguli
    Kari, Adilijiang
    Song, Chuanlong
    Abuduhaer, Abulaiti
    CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2021, 19 (01) : 120 - 126
  • [35] Exercise Preconditioning Regulates the Toll-Like Receptor 4/Nuclear Factor-κB Signaling Pathway and Reduces Cerebral Ischemia/Reperfusion Inflammatory Injury: A Study in Rats
    Zhu, Luwen
    Ye, Tao
    Tang, Qiang
    Wang, Yan
    Wu, Xiaojun
    Li, Hongyu
    Jiang, Yunfei
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (11): : 2770 - 2779
  • [36] Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
    Michelsen, KS
    Wong, MH
    Shah, PK
    Zhang, WX
    Yano, JA
    Doherty, TM
    Akira, S
    Rajavashisth, TB
    Arditi, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (29) : 10679 - 10684
  • [37] Atractylenolide-I Suppresses Tumorigenesis of Breast Cancer by Inhibiting Toll-Like Receptor 4-Mediated Nuclear Factor-κB Signaling Pathway
    Long, Fangyi
    Lin, Hong
    Zhang, Xiqian
    Zhang, Jianhui
    Xiao, Hongtao
    Wang, Ting
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [38] Myeloid differentiation factor 2 inhibitors exert protective effects on lipopolysaccharides-treated human dental pulp cells via suppression of toll-like receptor 4-mediated signaling
    Vaseenon, Savitri
    Srisuwan, Tanida
    Liang, Guang
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    JOURNAL OF DENTAL SCIENCES, 2024, 19 (01) : 220 - 230
  • [39] Impacts of Anthocyanin on Apoptosis and Toll-Like Receptor 4/Cyclooxygenase 2/Nuclear Factor-Kappa B Signaling Pathway in Rats with Spinal Cord Ischemia-Reperfusion Injury
    Chen, X.
    Zhu, J.
    Zhang, H.
    Xu, Fei
    Guo, Songhua
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 (04) : 936 - 943
  • [40] IL-4-dependent Th2 collateral priming to inhaled antigens independent of toll-like receptor 4 and myeloid differentiation factor 88
    Eisenbarth, SC
    Zhadkevich, A
    Ranney, P
    Herrick, CA
    Bottomly, K
    JOURNAL OF IMMUNOLOGY, 2004, 172 (07): : 4527 - 4534